Business
Board Changes
Board Changes.
About this update from Haleon Plc
[{"type":"text","content":"\n\n \n\n \nHaleon plc: Board Changes\n \n5 December 2024: Haleon plc (the \"Company\" or \"Haleon\") (LSE/NYSE: HLN) today announces the following changes to the Board.\n \nFollowing the reduction of Pfizer Inc.'s shareholding in Haleon plc below 20%, and in line with the Pfizer Relationship Agreement with Haleon plc, David Denton, Non-Executive Director and\nrepresentative of Pfizer Inc., stepped down from the Board on 4 December 2024.\n \nBláthnaid Bergin has been appointed as an independent Non-Executive Director and will join the Haleon Board on 24 February 2025.\n \nBláthnaid Bergin brings financial leadership and strategic planning experience from a variety of consumer-facing businesses. Bláthnaid is currently the Chief Financial Officer of J Sainsbury plc, where she has played a pivotal role in driving the company's financial strategy and operational efficiency initiatives. Prior to joining Sainsbury's, Bláthnaid held senior finance leadership and international positions at Aviva, RSA and GE working across Europe, Asia and Australia. She is a Chartered Accountant. Bláthnaid was previously Non-Executive Director, Chair of the Audit Committee and Senior Independent Director for Artemis Alpha Investment Trust.\n \nSir Dave Lewis, Haleon's Chair commented: \"On behalf of the Board, I would like to thank Dave for his insights and contributions to the Board's discussions. We wish him all the very best for the future. I would like to welcome Bláthnaid to Haleon. With her strong track record of financial leadership and transformation from multiple consumer-facing businesses, Bláthnaid brings a wealth of relevant skills and experience to the Board.\"\n \nThe Company confirms that there is no further information to be disclosed under the requirements of UKLR 6.4.6R and 6.4.8R.\n \nAmanda Mellor \nCompany Secretary \n \nAbout Haleon\nHaleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trust...